107: How the MTHFR Gene Affects Our Metabolic Health with Dr. Ben Bikman

Dr. Bikman built a case that dietary folate quality matters enormously for those with impaired MTHFR activity. He described how the enzyme product 5-MTHF is the methyl donor, and those with up to 70% reduced enzyme activity have difficulty making it. Animal liver offers the finished, reduced molecule, ready for use without enzymatic conversion. In contrast, plant folates are polyglutamate forms that require deconjugation and are trapped in cell walls; even after cooking, absorption is limited. He noted that 3 oz of chicken liver provides about five times the usable folate of cooked spinach, and the form is immediately accessible. His tone was unapologetically in favor of animal sources, suggesting this strategy is rarely discussed in conventional folate recommendations.

Bikman suggested starting with a simple blood panel—homocysteine, folate, B12—to get a snapshot of methylation function. If those are deranged, or if someone just wants deeper clarity, genetic testing can confirm the presence of the C677T or A1298C polymorphisms. He underscored how remarkably common these variants are (30–50% of people), so awareness is valuable. He framed testing as a practical first step before jumping to supplementation, because knowing your status helps tailor the approach (e.g., whether you need more B12, methylfolate, or just dietary adjustments). He added the standard caveat to consult a healthcare provider for interpretation, not to treat the lecture as medical advice.

Bikman was careful to say that supplementation should be targeted and smart, not a blanket recommendation. If testing reveals deficiencies or someone experiences methylation-related symptoms, using methylated B vitamins—specifically L-5-MTHF instead of folic acid, methylcobalamin instead of cyanocobalamin, and P5P instead of pyridoxine HCl—ensures the body receives the active cofactors without depending on the sluggish MTHFR enzyme. He stressed the importance of medical guidance for dosing because individual needs vary based on genetics, diet, and symptom severity. He reiterated that this lecture is educational, not prescriptive medical advice.

Dr. Bikman explained that when methylation is impaired and SAMe levels fall, the liver becomes less capable of oxidizing fatty acids for energy. This leads to an accumulation of triglycerides, cholesterol esters, and phospholipids within liver cells, setting the stage for fatty liver disease. He particularly emphasized that this problem is compounded by a high-insulin diet because insulin actively shuts down the enzymes involved in fatty acid oxidation. His trademark metaphor described the liver as the 'soccer mom of nutrient metabolism' — involved with every fuel. He also noted that elevated homocysteine increases oxidative stress, which peroxidizes lipids, and that MTHFR variants may make the already problematic peroxidation of omega-6 linoleic acid from seed oils even more likely. The overall message: MTHFR variants lower the liver’s ability to burn fat, and dietary insulin adds a second block, dramatically increasing fatty liver risk.

Dr. Bikman explained that the MTHFR enzyme converts folate into 5-methyltetrahydrofolate (5-MTHF), the active methyl donor. With a variant causing up to 70% loss of activity, making 5-MTHF from plant folate is inefficient. He pointed out that 3 oz of chicken liver provides ~500 micrograms of folate, and beef liver roughly half that, but critically both contain the highly bioavailable 5-MTHF form directly. In contrast, leafy greens like spinach and kale give only about 100 micrograms when cooked, and still much less if raw, because the folate is in a polyglutamate form that must be enzymatically cleaved before absorption. Cooking (steaming/sautéing) helps release some by breaking cell walls, but additional processing is still needed. He stated bluntly that he 'unapologetically' thinks animal sources are more prudent for those seeking dietary folate to support methylation.